ReShape and Obalon Expect to Complete Merger After Market Close
ReShape and Obalon Expect to Complete Merger After Market Close
DJ ReShape and Obalon Expect to Complete Merger After Market Close
DJ Rehape和Obalon預計在收盤後完成合並
By Josh Beckerman
喬什·貝克曼(Josh Beckerman)著
ReShape Lifesciences Inc. and Obalon Therapeutics Inc., which focus on medical devices for weight loss, expect to complete their merger after the close of the market Tuesday.
專注於減肥醫療設備的重塑生命科學公司(Rehape Lifesciences Inc.)和奧巴隆治療公司(Obalon Treateutics Inc.)預計將在週二市場收盤後完成合並。
Shares of Nasdaq-listed Obalon were recently up 7% to $3.47. OTCQB-listed ReShape was down 7% to $5.11.
在納斯達克(Nasdaq)上市的Obalon股價最近上漲7%，至3.47美元。在OTCQB上市的Rehape股價下跌7%，至5.11美元。
The merged company's stock is expected to begin trading on the Nasdaq Capital Market Wednesday, under the ReShape name and symbol "RSLS."
合併後的公司股票預計將於週三在納斯達克資本市場(Nasdaq Capital Market)開始交易，新的名稱和代碼為“RSLS”。
Write to Josh Beckerman at josh.beckerman@wsj.com
寫信給喬什·貝克曼(Josh Beckerman)，電子郵件：josh.beckerman@wsj.com
(END) Dow Jones Newswires
(完)道瓊通訊社
June 15, 2021 14:30 ET (18:30 GMT)
2021年6月15日東部時間14：30(格林尼治標準時間18：30)
Copyright (c) 2021 Dow Jones & Company, Inc.
版權所有(C)2021年道瓊斯公司
